CA-15.3: Prognostic factor in breast cancer

被引：1
|
作者：
Vialard, F
Basuyau, JP
Gligorov, J
Boccara, C
Graic, Y
Veyret, C
Julien, JP
机构：
[1] CRLCC Henri Becquerel, Dept Biol, Rouen, France
[2] CRLCC Henri Becquerel, Dept Clin Oncol, Rouen, France
[3] CRLCC Henri Becquerel, Dept Radiat Therapy, Rouen, France
[4] CRLCC Henri Becquerel, Dept Surg, Rouen, France
来源：
EUROPEAN JOURNAL OF CANCER | 1998年 / 34卷
关键词：
D O I：
10.1016/S0959-8049(98)80412-7
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
456
引用
收藏
页码：S100 / S100
页数：1
相关论文
共 50 条
  • [21] Prognostic value of serum CA 15.3, CEA and ESR in breast cancer
    Rubach, M
    Szymendera, JJ
    Kaminska, J
    Kowalska, M
    ANNALS OF ONCOLOGY, 1998, 9 : 29 - 29
  • [22] CORRELATION BETWEEN SERUM CONCENTRATIONS OF CA-15.3 AND ESTRADIOL IN FEMALES WITH MACROCYSTIC BREAST DISEASE
    VIZOSO, F
    ALLENDE, MT
    FUEYO, A
    VIVANCO, J
    MEDICINA CLINICA, 1990, 94 (20): : 798 - 798
  • [23] RELATIONS OF TUMOR-MARKERS - MCA AND CA-15.3
    BIEGLMAYER, C
    BIOLOGICAL CHEMISTRY HOPPE-SEYLER, 1988, 369 (09): : 797 - 797
  • [24] CA-549 AND SP2 IN POSTOPERATIVE BREAST-CANCER PATIENTS - COMPARISON WITH CA-15.3, CEA AND TPA
    TORRES, M
    PACHECO, C
    VALVERDE, A
    REBOLLO, AC
    MORAL, A
    VALLEJO, JA
    MATEO, A
    INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 1995, 10 (02): : 94 - 99
  • [25] SERUM TISSUE POLYPEPTIDE SPECIFIC ANTIGEN (TPS) IN BREAST-CANCER PATIENTS - COMPARISON WITH CA-15.3 AND CEA
    WILLSHER, PC
    BEAVER, J
    BLAMEY, RW
    ROBERTSON, JFR
    ANTICANCER RESEARCH, 1995, 15 (04) : 1609 - 1611
  • [26] THE COMPARATIVE INCIDENCE OF ELEVATION OF TUMOR-MARKERS CA-549, CA-15.3, AND CEA IN THE SERA OF BREAST-CANCER PATIENTS
    WERNEKE, DK
    ELLIOTT, RL
    BRAY, KR
    CLINICAL CHEMISTRY, 1989, 35 (06) : 1078 - 1078
  • [27] Prognostic role of CA15.3 in 7942 patients with operable breast cancer
    Sandri, M. T.
    Salvatici, M.
    Botteri, E.
    Passerini, R.
    Zorzino, L.
    Rotmensz, N.
    Luini, A.
    Mauro, C.
    Bagnardi, V.
    Cassatella, M. C.
    Bottari, F.
    Casadio, C.
    Colleoni, M.
    BREAST CANCER RESEARCH AND TREATMENT, 2012, 132 (01) : 317 - 326
  • [28] COMPARISON OF TUMOR-MARKERS CEA, CA-125, CA-15.3 AND PROLACTIN LEVELS IN PATIENTS WITH ADVANCED BREAST-CANCER
    TSAVARIS, N
    VONORTA, K
    SARAFIDOU, M
    BACOYIANNIS, C
    MYLONAKIS, N
    BEER, M
    PAPAGRIGORIOU, D
    KOUTSIOUBAKAZAKOU, P
    KOSMIDIS, P
    DIAGNOSTIC ONCOLOGY, 1992, 2 (04): : 211 - 219
  • [29] Prognostic role of CA15.3 in 7942 patients with operable breast cancer
    M. T. Sandri
    M. Salvatici
    E. Botteri
    R. Passerini
    L. Zorzino
    N. Rotmensz
    A. Luini
    C. Mauro
    V. Bagnardi
    M. C. Cassatella
    F. Bottari
    C. Casadio
    M. Colleoni
    Breast Cancer Research and Treatment, 2012, 132 : 317 - 326
  • [30] The value of serum CA-15.3, DNA ploidy and cell cycle kinetics in breast tumors.
    Bahig, T
    Eissa, S
    Emad, L
    CLINICAL CHEMISTRY, 1997, 43 : 555 - 555
12345